Welcome to our dedicated page for Caci Intl SEC filings (Ticker: CACI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CACI International Inc (NYSE: CACI) SEC filings page brings together the company’s official U.S. Securities and Exchange Commission disclosures, offering investors a structured view of how this national security-focused information solutions and services provider reports material events, financing arrangements, governance actions, and strategic transactions. CACI’s filings appear under its registrant name and document its activities as a public company serving primarily U.S. government agencies and departments.
Through this page, readers can access current and historical Forms 8-K in which CACI reports items such as quarterly and annual financial results, amendments to credit agreements, accounts receivable purchase arrangements, incentive compensation plans, and board and committee matters. Recent 8-K filings, for example, describe a Second Amended and Restated Credit Agreement with specified term loan and revolving credit facilities, amendments to a Master Accounts Receivable Purchase Agreement, and shareholder approval of the CACI International Inc 2025 Incentive Compensation Plan.
Filings also capture strategic transactions and acquisition agreements. An 8-K dated December 22, 2025 outlines a Purchase Agreement and Plan of Merger under which a CACI subsidiary agreed to acquire ARKA Group L.P. for an aggregate cash purchase price, subject to customary conditions and regulatory approvals. Related disclosures include information on planned debt financing commitments and bridge loan facilities associated with that transaction.
Investors can use this page to locate quarterly and annual reports (Forms 10-Q and 10-K when available), which provide more detailed discussions of segment operations, risk factors, and financial statements, as well as proxy materials such as the DEF 14A that describe director elections, advisory votes on executive compensation, and auditor ratification. Stock Titan’s platform adds AI-powered summaries to help explain the key points in lengthy filings, highlight important sections, and make it easier to interpret complex topics like leverage covenants, incentive plans, and acquisition structures.
For users analyzing CACI stock, this SEC filings page serves as a centralized resource for understanding how the company documents its national security-oriented business, capital structure, governance, and material events in its official regulatory reports.
CACI International Inc. (CACI) reported a Form 4 for Director and Chair of the Board Lisa Disbrow. On October 16, 2025, she was granted 53 shares of CACI common stock as part of her annual retainer and 492 Restricted Stock Units (RSUs).
The RSUs vest in four equal tranches of 123 shares on January 14, 2026, April 14, 2026, July 13, 2026, and October 11, 2026. Following the grant, she beneficially owned 1,987 CACI shares directly, and 492 RSUs as derivative securities.
CACI International Inc. (CACI) director Stanton D. Sloane reported an equity award on a Form 4. On October 16, 2025, he acquired 338 Restricted Stock Units (RSUs), listed as derivative securities tied to CACI common stock.
The RSUs vest in four installments during 2026: 84 shares on January 14, 84 shares on April 14, 85 shares on July 13, and 85 shares on October 11. Following this grant, the filing shows 338 derivative securities beneficially owned, held directly.
This is a routine director compensation grant disclosed under Section 16, with a defined vesting schedule that spreads delivery over the 2026 calendar year.
CACI International Inc. disclosed a Form 4 showing Director Charles L. Szews received 338 Restricted Stock Units (RSUs) on October 16, 2025.
The award vests in four installments during 2026: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. The filing lists the RSUs in Table II as acquired and directly owned, with 338 derivative securities beneficially owned following the transaction.
This is a routine equity compensation grant to a director and does not indicate cash proceeds to the company.
CACI International (CACI) reported an insider equity award. Director Ryan D. McCarthy received 338 Restricted Stock Units on October 16, 2025. These RSUs convert into shares of CACI common stock as they vest: 84 on January 14, 2026; 84 on April 14, 2026; 85 on July 13, 2026; and 85 on October 11, 2026.
The filing shows the grant as an acquisition of derivative securities with direct ownership. RSUs typically represent a form of equity compensation that settles in stock upon vesting, aligning directors’ interests with long-term shareholder value.
CACI International Inc. (CACI) reported an insider transaction on a Form 4. Director Philip O. Nolan acquired 83 shares of CACI common stock on 10/12/2025 via settlement of restricted stock units, noted with transaction code M. After this transaction, he beneficially owned 2,069 shares directly. These RSUs were part of a 331‑unit grant from 10/17/2024 with scheduled vesting of 82 shares on 1/15/2025, 83 shares on 4/15/2025, 83 shares on 7/14/2025, and 83 shares on 10/12/2025.
CACI International (CACI) director Stanton D. Sloane reported the vesting and settlement of 83 Restricted Stock Units on October 12, 2025, resulting in the acquisition of 83 shares of CACI common stock (transaction code M).
Following this transaction, Sloane beneficially owns 859 shares, held directly. The RSUs were part of a 331-unit grant made on October 17, 2024, scheduled to vest in four tranches: 82 shares on January 15, 2025; 83 on April 15, 2025; 83 on July 14, 2025; and 83 on October 12, 2025.
CACI International Inc. (CACI) reported an insider equity change by director Debora A. Plunkett. On October 12, 2025, 83 shares of CACI common stock were acquired via an RSU vesting event (transaction code M). Following this transaction, Ms. Plunkett beneficially owned 2,564 shares, held directly.
The activity relates to a prior grant of 331 Restricted Stock Units awarded on October 17, 2024, with scheduled vesting as follows: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025.
CACI International Inc.: Director Ryan D. McCarthy reported the vesting and settlement of 83 restricted stock units into CACI common stock on October 12, 2025 (Transaction Code M). Following this transaction, he beneficially owned 2,069 shares directly.
The RSUs were granted on October 17, 2024 (331 total) with a vesting schedule of 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025.
CACI International (CACI) director Scott Morrison reported the vesting and settlement of restricted stock units into common stock. On 10/12/2025, a transaction coded M converted RSUs into 83 shares of CACI common stock. Following the transaction, Morrison beneficially owns 331 shares directly.
The activity reflects the final tranche of a previously disclosed 331 RSU grant made on October 17, 2024, which vested in scheduled installments across 2025, concluding with 83 shares on October 12, 2025.
CACI International (CACI) reported an insider equity change by Director William L. Jews. On October 12, 2025, 83 shares of CACI common stock were acquired through the conversion of vested RSUs (Code M), increasing his direct holdings to 6,384 shares.
The transaction reflects the final tranche from a 331 RSU grant awarded on October 17, 2024, which vested in installments: 82 shares on January 15, 2025; 83 shares on April 15, 2025; 83 shares on July 14, 2025; and 83 shares on October 12, 2025.
FAQ
What is the current stock price of Caci Intl (CACI)?
What is the market cap of Caci Intl (CACI)?
